» Articles » PMID: 37275311

Right Ventricular Reverse Remodeling After Tricuspid Valve Surgery for Significant Tricuspid Regurgitation

Overview
Journal Struct Heart
Publisher Elsevier
Date 2023 Jun 5
PMID 37275311
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Changes in right ventricular (RV) dimensions and function after tricuspid valve (TV) surgery and their association with long-term outcomes remain largely unexplored. The current study evaluated RV reverse remodeling, based on changes in RV dimensions and function, after TV surgery for significant (moderate or severe) tricuspid regurgitation (TR) and their association with outcome.

Methods: A total of 121 patients (mean age 63 ± 12 years, 47% males) with significant TR treated with TV surgery were included in this analysis. The population was stratified by tertiles of percentage reduction of RV end-systolic area (RVESA) and absolute change of RV fractional area change (RVFAC). Five-year mortality rates were compared across the tertiles of RV remodeling and independent associates of mortality were investigated.

Results: Tertile 3 consisted of patients presenting with a reduction in RVESA ≥17.2% and an improvement in RVFAC ≥2.3% after TV surgery. Cumulative survival rates were significantly better in patients within tertile 3 of RVESA reduction: 90% vs. 49% for tertile 1 and 69% for tertile 2 (log-rank = 0.002) and within tertile 3 of RVFAC improvement: 87% vs. 57% for tertile 1 and 65% for tertile 2 (log-rank = 0.02). Tertiles 3 of RVESA reduction and RVFAC improvement were both independently associated with better survival after TV surgery compared to tertiles 1 (hazard ratio: 0.221 [95% CI: 0.074-0.658] and 0.327 [95% CI: 0.118-0.907], respectively).

Conclusions: The extent of RV reverse remodeling, based on reduction in RVESA and improvement in RVFAC, was associated with better survival at 5-year follow-up of TV surgery for significant TR.

Citing Articles

Concomitant tricuspid valve surgery in patients undergoing left ventricular assist device: a systematic review and meta-analysis.

Luo Y, Leng J, Shi R, Jiang Y, Chen D, Wu Q Int J Surg. 2024; 110(5):3039-3049.

PMID: 38348836 PMC: 11093502. DOI: 10.1097/JS9.0000000000001189.

References
1.
Nath J, Foster E, Heidenreich P . Impact of tricuspid regurgitation on long-term survival. J Am Coll Cardiol. 2004; 43(3):405-9. DOI: 10.1016/j.jacc.2003.09.036. View

2.
Dietz M, Prihadi E, Van der Bijl P, Goedemans L, Mertens B, Gursoy E . Prognostic Implications of Right Ventricular Remodeling and Function in Patients With Significant Secondary Tricuspid Regurgitation. Circulation. 2019; 140(10):836-845. DOI: 10.1161/CIRCULATIONAHA.119.039630. View

3.
Dreyfus G, Corbi P, Chan K, Bahrami T . Secondary tricuspid regurgitation or dilatation: which should be the criteria for surgical repair?. Ann Thorac Surg. 2004; 79(1):127-32. DOI: 10.1016/j.athoracsur.2004.06.057. View

4.
Bax J, Braun J, Somer S, Klautz R, Holman E, Versteegh M . Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004; 110(11 Suppl 1):II103-8. DOI: 10.1161/01.CIR.0000138196.06772.4e. View

5.
Chikwe J, Itagaki S, Anyanwu A, Adams D . Impact of Concomitant Tricuspid Annuloplasty on Tricuspid Regurgitation, Right Ventricular Function, and Pulmonary Artery Hypertension After Repair of Mitral Valve Prolapse. J Am Coll Cardiol. 2015; 65(18):1931-8. DOI: 10.1016/j.jacc.2015.01.059. View